CTI(SZ:300012) Xin Lang Zheng Quan·2025-10-23 06:30Core Viewpoint - 华测检测's stock price has shown a positive trend, with a year-to-date increase of 17.82% and a recent uptick in trading activity, indicating investor interest and potential growth in the company's market position [1][2]. Financial Performance - For the first half of 2025, 华测检测 reported a revenue of 2.96 billion yuan, reflecting a year-on-year growth of 6.05%, while the net profit attributable to shareholders was 467 million yuan, up 7.03% compared to the previous year [2]. - Cumulatively, since its A-share listing, the company has distributed a total of 1.16 billion yuan in dividends, with 519 million yuan distributed over the last three years [3]. Shareholder Structure - As of June 30, 2025, 华测检测 had 81,100 shareholders, an increase of 4.53% from the previous period, with an average of 17,647 circulating shares per shareholder, down 4.34% [2]. - The largest circulating shareholder is Hong Kong Central Clearing Limited, holding 269 million shares, which increased by 7.87 million shares from the previous period [3]. Stock Performance - 华测检测's stock price reached 14.47 yuan per share, with a trading volume of 456 million yuan and a turnover rate of 2.25%, leading to a total market capitalization of 24.35 billion yuan [1]. - The stock has experienced a 1.47% increase over the last five trading days, an 11.22% increase over the last 20 days, and a 19.49% increase over the last 60 days [1]. Business Segments - The company's main business segments include life sciences (43.02% of revenue), industrial testing (20.31%), consumer product testing (17.64%), trade assurance (14.39%), and medical services (4.64%) [1].